The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback